| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |